Keep up with personal finance and investing trends. Stock Market, Mutual Funds, Insurance, and lot more.
All that you should know about the Company before applying for the IPO.
The public issue of equity shares of GLOBAL HEALTH LIMITED will open for subscription on November 03, 2022 and closes on November 07, 2022. It is expected to list on the stock exchanges on November 16, 2022. What does the company do? Why is the company going public? Who are its key competitors? Its key strengths, and lot more. Here’s everything that you want to know about the company to analyse the IPO.
Global Health Ltd. is one of the largest private multi-specialty tertiary care providers in terms of bed capacity and operating revenues, with operations in the northern and eastern regions of India. Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon, founded the company. The company possesses key specialties in cardiology, cardiac science, neuroscience, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplants, and kidney and urology. Their hospital at Gurugram was ranked as the best private hospital in India for three consecutive years in 2020, 2021, and 2022 by Newsweek.
The company provides healthcare services in over 30 different specialties and engages more than 1,300 doctors who are led by experienced department heads on a 4.7 million sq. ft. campus of operational hospitals with 2,467 installed beds.
The company has a presence in various major cities like Gurugram, Indore, Ranchi, Lucknow, Patna, etc. The company also operates six multi-specialty clinics at DLF Cybercity Gurugram, Delhi Airport, south Delhi, Darbhanga, Patna, and Subhash Chowk Gurugram.
Dr. Naresh Trehan
Given below are the objectives of the Company –
The Offer comprises a Fresh Issue by the company and an Offer for Sale by the selling shareholders. The company will not receive any proceeds from the Offer for Sale.
The Company proposes to utilise the Net Proceeds from the Fresh Issue towards funding of the following objects:
|IPO Size||₹ 2,205.57 Crore*|
|Offer Mix||Fresh issue ₹ 500 Crore + Offer For Sell ₹ 1,705.57 Crore*|
|Price Band||₹ 319 - ₹ 336|
|Lot Size||44 Shares (& in multiples thereof)|
|Face Value||₹ 2|
|Application Amount||Min. ₹ 14,784 (1 lot) | Max. ₹ 1,92,192 (13 lots) [at upper price band]|
|Listing on||NSE & BSE|
|Registrar||KFin Technologies Limited|
|Cut-off time for UPI Mandate Confirmation||07-November-2022 (up to 05:00 PM)|
₹ 1,102.78 Crore
(50% of the Issue Size)
₹ 330.84 Crore
(15% of the Issue Size)
₹ 771.95 Crore
(35% of the Issue Size)
|IPO Opens||November 03, 2022|
|IPO Closes||November 07, 2022|
|Finalization of the basis of allotment||November 11, 2022|
|Unblocking of funds / Initiation of refunds||November 14, 2022|
|Credit of equity shares to Demat accounts||November 15, 2022|
|Listing of equity shares||November 16, 2022|
Apply online in just 5 minutes!Apply Now Investment in securities market is subject to market risks, read all the related documents carefully before investing.
Wealthstreet is one-stop solution for all your financial requirements.
© 2021 Wealthstreet Financial Services Private Limited. All Right Reserved.
Wealthstreet refers to Wealthstreet Financial Services Private Limited. Wealthstreet Financial Services Private Limited: INZ000157331 (Member of NSE, BSE and MCX). Wealthstreet Financial Services Private Limited acts in the capacity of a distributor for Mutual Funds having AMFI Registration Number – 118251.
Mutual Fund Investments are subject to market risks. Please read all scheme related documents carefully before investing. Investment in the securities involves risks. The user is required to undergo risk profiling before investing. Guided view is indicative in nature and is based on the information provided by the user voluntarily. Each user of this information should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred here (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. Past performance is not necessarily a guide to future performance.
The information contained in this website is for general information purposes only. The information is provided by Accord Fintech Private Limited. While we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the timeliness, completeness, accuracy, reliability, suitability or availability with respect to the website or the information or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk. Wealthstreet Financial Services Private Limited shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this website.
Content Powered by Accord Fintech Pvt. Ltd.
Broking and DP services offered by Wealthstreet Financial Services Private Limited under SEBI Registration No.: INZ000157331 (Member of NSE, BSE and MCX) and IN-DP-CDSL-361-2018 (DP with CDSL). Investor grievance resolution team, Tel: 079-66775500, Email ID: email@example.com. Name of the Compliance Officer for Trading & DP – Mr. Suren Pandya, Email ID: firstname.lastname@example.org. Corporate Office: A – 1101, Mondeal Heights, S.G.Highway, Ahmedabad – 380015.; Tel. 079-66775500.
Link to SCORES portal – https://www.scores.gov.in/scores/Welcome.html